Biolexis Therapeutics, Inc.
PrivateLast Round
Seed Round
Jun 3, 2026
Total Funding Raised
$13.98M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Biolexis Therapeutics, Inc. is a biotechnology company that utilizes a proprietary AI-enabled platform for the discovery and development of small molecule therapeutics for metabolic, inflammatory, and other chronic diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Infrastructure
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Biolexis Therapeutics, Inc. Comparables
Compare Biolexis Therapeutics, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Ambrosia Biosciences Inc. | 83% | |
| Syntis Bio, Inc. | 82% | |
| Verdiva Bio | 81% | |
Biolexis Therapeutics, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed Round | Jun 3, 2026 | ||||
| Series A | Nov 22, 2023 | ||||
| Seed | Oct 3, 2023 | ||||
| Seed | Sep 2, 2022 | ||||
| Debt | Feb 14, 2022 |
Biolexis Therapeutics, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Clarke Capital Partners | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 17, 2026
Monthly visitors grew 427% MoM, from 280 to 1.5K.
- Jun 3, 2026
$1.6M raised in Seed Round funding.
Biolexis Therapeutics, Inc. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Biolexis Therapeutics, Inc.'s valuation, stock price, and market status.